Skip to main content
TOWA PHARMACEUTICAL CO.,LTD. logo

TOWA PHARMACEUTICAL CO.,LTD. — Investor Relations & Filings

Ticker · 4553 ISIN · JP3623150004 LEI · 35380036BH1C3PNO2426 T Manufacturing
Open in API
Filings indexed 64 across all filing types
Latest filing 2025-11-11 Regulatory Filings
Country JP Japan
Listing T 4553

About TOWA PHARMACEUTICAL CO.,LTD.

https://www.towayakuhin.co.jp/english/

TOWA PHARMACEUTICAL CO.,LTD. is a pharmaceutical company specializing in the research, development, manufacturing, and marketing of generic drugs. Founded in 1951, the company is dedicated to providing high-quality and high added-value therapeutic solutions. Its product portfolio primarily consists of generic medications, which are distributed as ethical drugs, and also includes other products such as vitamins and antibiotics. The company focuses on the entire lifecycle of its pharmaceutical products, from initial development to final distribution, to meet various healthcare needs.

Recent filings

Filing Released Lang Actions
確認書
Regulatory Filings Classification · 1% confidence The document is titled '確認書' (Confirmation Letter) and explicitly cites '金融商品取引法第24条の5の2第1項' (Article 24-5-2, Paragraph 1 of the Financial Instruments and Exchange Act). It serves as an officer certification regarding the accuracy of a semi-annual report. According to the 'CERTIFICATION RULE', documents that are primarily officer certifications or attestations should be classified as Regulatory Filings (RNS), even if they reference a specific report type like a semi-annual report. H1 70
2025-11-11 Japanese
半期報告書－第70期(2025/04/01－2026/03/31)
Interim / Quarterly Report Classification · 1% confidence The document is a '半期報告書' (Semi-Annual Report) filed by Towa Pharmaceutical Co., Ltd. with the Kinki Finance Bureau under the Financial Instruments and Exchange Act. It contains comprehensive financial statements, including the balance sheet, income statement, and management analysis for the interim period ending September 30, 2025. As it is a formal, comprehensive financial report for a period shorter than a full fiscal year, it is classified as an Interim/Quarterly Report. H1 70
2025-11-11 Japanese
臨時報告書
AGM Information Classification · 1% confidence The document is titled "臨時報告書" (Extraordinary Report/Timely Disclosure Report) and explicitly states in Section 1 that it is being submitted because resolutions were passed at the Annual General Meeting (定時株主総会) held on June 25, 2025, in accordance with financial regulations. Section 2 details the resolutions, which include the approval of the surplus appropriation (dividend) and the election/re-election of directors. This content—reporting the results of a shareholder meeting—perfectly matches the definition of 'Declaration of Voting Results & Voting Rights Announcements' (DVA). Although it relates to the AGM, the core purpose is reporting the *results* of the vote, not providing the meeting materials (AGM-R) or proxy information (PSI). The document is short and serves as a formal disclosure of the outcome.
2025-06-27 Japanese
内部統制報告書－第69期(2024/04/01－2025/03/31)
Governance Information Classification · 1% confidence The document explicitly states in the header table that the filing document is a "内部統制報告書" (Internal Control Report) and cites the legal basis as Article 24-4-4, Paragraph 1 of the Financial Instruments and Exchange Act (金融商品取引法第24条の4の4第1項). The content discusses the framework, scope, criteria, and results of the assessment of internal controls over financial reporting (財務報告に係る内部統制). This directly corresponds to the requirements for an internal control report, which is a mandatory disclosure in Japan, often filed alongside the Annual Securities Report (which is the equivalent of the 10-K, but the specific document provided here is the control report itself). While the content relates to the annual cycle, it is not the full Annual Report (10-K) or a general Audit Report (AR). In the provided classification scheme, there is no direct code for a standalone 'Internal Control Report'. However, based on the nature of the content—a formal report detailing internal controls and assessment results—it is most closely related to formal regulatory reporting concerning financial integrity. Given the options, 'AR' (Audit Report / Information) is the closest fit as it covers reports applied accounting principles and results of internal/regulatory stress tests, although 'Internal Control Report' is a distinct category in Japanese filings. Since the document is a comprehensive, formal report detailing internal controls and assessment results, and not just an announcement of a report (Rule 2), it should be classified as the report itself. 'AR' is the best available proxy for a formal, non-10-K financial assurance/control document.
2025-06-24 Japanese
有価証券報告書－第69期(2024/04/01－2025/03/31)
Annual Report Classification · 1% confidence The document is identified as a Japanese 'Yuka Shoken Hokokusho' (Securities Report), which is the Japanese equivalent of the US 10-K. It contains a formal cover page, specifies the fiscal year (2024-04-01 to 2025-03-31), and includes XBRL-like tagging for financial data, confirming it is the comprehensive annual financial report rather than an announcement or summary. FY 2025
2025-06-24 Japanese
確認書
Audit Report / Information Classification · 1% confidence The document text contains Japanese characters and includes the header "有価証券報告書（通常方式）" which translates to 'Securities Report (Normal Method)'. It also explicitly mentions the submission date, company name (Towa Pharmaceutical Co., Ltd.), and confirms that the content of the '第69期...有価証券報告書' (69th period Securities Report) is appropriate according to financial instruments laws. A Securities Report in the context of Japanese regulatory filings is the equivalent of the US 10-K (Annual Report). Although the document itself is a '確認書' (Confirmation Document) regarding the accuracy of the Securities Report, the core subject matter and context strongly point to the Annual Report filing cycle. Given the options, 10-K is the closest equivalent for a comprehensive annual report filing. FY 2025
2025-06-24 Japanese

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.